Express Pharma

Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile idiopathic arthritis

Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight

0 851

Pfizer announced that the United States (US) Food and Drug Administration (FDA) approved XELJANZ (tofacitinib) for